ISCT Executive Committee Oversight on Committee Membership

  • If the % composition of Industry representatives on the ISCT Commercialization committee exceeds 60%, the committee composition will be reviewed and approved by the ISCT executive board to ensure no industry segment is disproportionately represented.
  • Industry Community members can raise objections and concerns on proportional industry representation to the Commercialization co-chairs and the ISCT Executive Committee.

If you have any concerns about the proportion of industry representation and would like to discuss the matter, please email isct@celltherapysociety.org